CARLSBAD, Calif. — Patients with uveal melanoma who had Medicaid or no insurance were less likely to receive brachytherapy and more likely to be diagnosed at later stages, according to a study presented here.
The findings suggest these patients likely face barriers in access to care, researchers wrote in a poster presented at the Women in Ophthalmology Summer Symposium.
“Uveal melanoma is a rare, primary intraocular cancer that only a select number of specialists and treatment centers are equipped to treat,” Victoria A. Marks, MD, of Yale School of Medicine (Read more...)